Mirati Therapeutics, Inc.

STATE STREET CORP

Report date

12/31/2023

Quarter

2023 Q4

Filed

2/14/2024

Shares

2,324,268

Value ($000)

136,551

Weight

0.0%

2019 Q4 - 2023 Q4 (17 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2023 Q4	2/14/2024	136,551	0.0%	2,324,268	12/31/2023
2023 Q3	11/14/2023	119,614	0.0%	2,745,968	9/30/2023
2023 Q2	8/14/2023	93,278	0.0%	2,581,739	6/30/2023
2023 Q1	5/15/2023	85,879	0.0%	2,309,820	3/31/2023
2022 Q4	5/15/2023	115,340	0.0%	2,545,576	12/31/2022
2022 Q3	11/15/2022	109,756	0.0%	1,571,539	9/30/2022
2022 Q2	8/15/2022	125,977	0.0%	1,876,615	6/30/2022
2022 Q1	5/16/2022	117,046	0.0%	1,423,565	3/31/2022
2021 Q4	2/14/2022	151,892	0.0%	1,035,464	12/31/2021
2021 Q3	11/15/2021	161,981	0.0%	915,613	9/30/2021
2021 Q2	8/16/2021	135,633	0.0%	839,678	6/30/2021
2021 Q1	7/9/2021	181,265	0.0%	1,058,171	3/31/2021
2020 Q4	2/16/2021	236,340	0.0%	1,076,033	12/31/2020
2020 Q3	11/10/2020	180,636	0.0%	1,087,840	9/30/2020
2020 Q2	8/14/2020	141,137	0.0%	1,236,198	6/30/2020
2020 Q1	6/19/2020	97,763	0.0%	1,271,796	3/31/2020
2019 Q4	2/6/2020	159,111	0.0%	1,234,762	12/31/2019